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Abstract
Background: Genes involved in hepatic metabolism have a sex-different expression in rodents. To test whether
male and female rat livers differ regarding lipid and carbohydrate metabolism, whole-genome transcript profiles
were generated and these were complemented by measurements of hepatic lipid and glycogen content, fatty acid
(FA) oxidation rates and hepatic glucose output (HGO). The latter was determined in perfusates from in situ
perfusion of male and female rat livers. These perfusates were also analysed using nuclear magnetic resonance
(NMR) spectroscopy to identify putative sex-differences in other liver-derived metabolites. Effects of insulin were
monitored by analysis of Akt-phosphorylation, gene expression and HGO after s.c. insulin injections.
Results: Out of approximately 3 500 gene products being detected in liver, 11% were significantly higher in
females, and 11% were higher in males. Many transcripts for the production of triglycerides (TG), cholesterol and
VLDL particles were female-predominant, whereas genes for FA oxidation, gluconeogenesis and glycogen synthesis
were male-predominant. Sex-differences in mRNA levels related to metabolism were more pronounced during mild
starvation (12 h fasting), as compared to the postabsorptive state (4 h fasting). No sex-differences were observed
regarding hepatic TG content, FA oxidation rates or blood levels of ketone bodies or glucose. However, males had
higher hepatic glycogen content and higher HGO, as well as higher ratios of insulin to glucagon levels. Based on
NMR spectroscopy, liver-derived lactate was also higher in males. HGO was inhibited by insulin in parallel with
increased phosphorylation of Akt, without any sex-differences in insulin sensitivity. However, the degree of Thr172-
phosphorylated AMP kinase (AMPK) was higher in females, indicating a higher degree of AMPK-dependent actions.
Conclusions: Taken together, males had higher ratios of insulin to glucagon levels, higher levels of glycogen,
lower degree of AMPK phosphorylation, higher expression of gluconeogenic genes and higher hepatic glucose
output. Possibly these sex-differences reflect a higher ability for the healthy male rat liver to respond to increased
energy demands.
Background
In most mammalian species post-pubertal growth, body
size and body composition are sexually dimorphic [1].
Muscle mass (especially upper body muscle mass) is
greater in males than females, whereas women generally
have a higher amount of body fat [2]. When obesity devel-
ops, women have a higher proportion of body fat in the
gluteal-femoral region, whereas men have more body fat
in the abdominal (visceral) region [3]. Since visceral obe-
sity is strongly correlated to the development of obesity-
related diseases (hyperlipidemia, hypertension, type-2
diabetes and cardiovascular disease), differences in body
composition might explain why the metabolic syndrome is
greater for men than age-matched premenopausal women
[4-6]. Other sex-dependent factors that may contribute to
a more insulin-sensitive environment in women than in
men include sex hormones and adipokines [7]. In addition,
nonalcoholic fatty liver disease (NAFLD) is closely asso-
ciated with metabolic disorders [8], and it has been shown
that male gender, waist circumference, triglyceride level,
and insulin resistance are independently associated with
NAFLD in non-obese subjects [9].
The prevalence of early abnormalities of glucose meta-
bolism has been estimated to be higher in men than in
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metabolic syndrome approximately ten years later than
men, it has been suggested that the endocrine status in
fertile women might be protective in this context. This has
been supported by data from animal studies showing that
ERKO (estrogen receptor a knockout) mice develop fatty
liver, hepatic insulin resistance and impaired glucose toler-
ance [11]. This indicates that down-stream effects of sex-
dependent hormones within the liver might play a role
during development of NAFLD. Improved insight regard-
ing sex-differences in hepatic lipid and carbohydrate
homeostasis may therefore facilitate attempts to unravel
the mechanisms behind metabolic disease development.
To gain a deeper insight into the sex-differentiated
activities of the liver, we [12] and others [13,14] have
previously used transcript profiling to identify gene pro-
ducts with sex-different expression levels. Although
these studies differ regarding design, it was jointly found
that genes involved in lipid, steroid and drug metabo-
lism have a sex-different expression in rodent liver. It
seems likely that sets of genes from specific metabolic
pathways are regulated in a coordinated manner and
that sex-dependent hormones have an important impact
on the long-term regulation of these genes. However,
since differences observed at the mRNA level are not
always translated into the same differences at the level
of protein function, transcript data need to be comple-
mented by functional studies.
The liver has a major role in energy storage after a
meal, as well as in the release of fuel molecules during
situations such as starvation. Based on previous studies
in both humans and animals [15], males might be pre-
dicted to more rapidly mobilize hepatic carbohydrates as
compared to females. Males are also more responsive to
peroxisome proliferators than female rats [16-19], includ-
ing higher rates of lipid oxidation. It might thus be
speculated that male livers have a greater production of
reactive oxygen species (ROS) during situations of
increased hepatic fat. NAFLD is believed to be caused by
fat accumulation in the liver and through increased ROS
production lead to hepatic insulin resistance [20]. Female
livers have been shown to be more efficient in packaging
long chain fatty acids into very-low-density-lipoprotein
(VLDL) particles [21], which might reduce the hepatocel-
lular load of lipids. Taken together, these differences
might possibly contribute to a higher risk of developing
hyperglycemia and hepatic insulin resistance in males as
compared to females during situations of increased hepa-
tic fat and/or insufficient insulin production.
Glycogen storage, release of glucose and ketone bodies
are major functions of the liver that differ depending on
the metabolic state of the individual. In this study we
aimed to substantiate the hypothesis that healthy (lean)
male and female rat livers differ regarding these
functions. We believe that this could provide a basis for
an improved understanding of which mechanisms that
might be involved in the development of sex-different
disease linked to the liver. Male and female rats, fed
standard diet and fasted for either 4 h or 12 h, were
compared regarding hepatic gene expression, lipid and
glycogen content, fatty acid (FA) oxidation rate, release
of glucose and ketone bodies. Furthermore, liver perfu-
sates were analysed using nuclear magnetic resonance
(NMR) spectroscopy to identify putative sex-differences
in other liver-derived metabolites.
Methods
Animals
Exp 1
Sex-dependent effects on hepatic gene expression in
non-fasted male and female rats: Seven-week-old male
(n = 5) and female (n = 5) Sprague-Dawley (SD) rats
(Scanbur BK) were maintained under standardized con-
ditions with free access to regular rodent chow (R36,
Lactamin, Sweden) and water. Rats were sacrificed
around noon, livers removed and frozen in liquid nitro-
gen. These livers were used for transcript profiling
(whole genome microarray analysis) only.
Exp 2
Effects of 4 h and 12 h fasting in male and female rats:
Seven-week-old male (n = 16) and female (n = 16) SD
rats (Scanbur BK) were maintained as described above.
Food was removed early in the morning (7 a.m.) or late
in the evening (11 p.m.), so that the animals were with-
out food for either 4 h (absorptive state) or 12 h (post-
absorptive state). Body weights were not significantly
altered by this short period of food deprivation (4 h
males 255.3 ± 6.6 g; 12 h males 238.8 ± 6.6 g; 4 h
females 213.3 ± 5.2 g; 12 h females 201.3 ± 3.1 g).
To determine rapid hepatic insulin responses, rats
were injected intraperitoneally (i.p.) with insulin (Actra-
pid, Novo Nordisk), at a dose of 5 mU/g body weight,
or saline only. After 40 minutes of treatment rats were
sacrificed, blood drawn from vena cava, livers removed
and frozen in liquid nitrogen. As described below, sepa-
rate animals (n = 32) were used for measurements of
hepatic glucose output (since perfused livers are unsui-
table for analyses such as gene expression). All animal
experiments were approved by the regional Ethics Com-
mittee on Animal Experiments.
Plasma and blood analysis
Blood was collected from vena cava in 10-mL tubes
containing 17.5 mg EDTA (Becton, Dickinson and Com-
pany). Plasma was obtained by centrifugation at 3000 g
for 10 min. The resulting supernatants were removed
and analysed for insulin, glucagon (RIA kits from Milli-
pore), corticosterone (EIA kit from Diagnostic Systems
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were anlysed in a drop of blood collected from the tip
of the tail using a Precision Xtra glucometer and test
strips (Abbot Scandinavia).
Expression profiling using microarrays
Microarrays containing 70 mer oligonucleotide probes
for 27 649 rat protein-coding genes were fabricated and
used to obtain transcript profiles, as described pre-
viously [22]. Each hybridisation compared Cy3-labeled
cDNA reverse transcribed from RNA isolated from
female rat livers with Cy5-labeled cDNA isolated from
male livers. Each experiment was analysed using indivi-
dual samples and dye-swopping. Identification of
sex-dependent genes was performed using the SAM
1.21 (Significance Analysis for Microarray) software
incorporated in Microsoft office Excel program. A 5%
false discovery rate was used as a first cut-off. Genes with
a greater than 1.5-fold difference between the sexes were
considered as being sex-dependent [12]. The results are
represented as the mean of at least three independent
determinations. All data are available from the NCBI
Gene Expression Omnibus database (GEO; http://www.
ncbi.nlm.nih.gov/geo/) using the series entry GSE20601.
Analysis of gene expression by real time quantitative RT-
PCR
Total hepatic RNA was isolated, cDNA generated and
gene expression quantified, as described previously [22].
The primers for the genes of interest are shown in table
1. The protocol was validated for each gene by checking
melting curves for the absence of primer-dimers or
other unwanted amplicons. The levels of individual
mRNAs were normalized with levels of the housekeep-
ing gene acidic ribosomal phosphoprotein Pθ (Arbp)
and the results expressed in arbitrary units.
Hepatic lipid content and fatty acid oxidation
Cellular lipids were extracted from rat liver using
chloroform and methanol (2:1, vol/vol), using the Folch
method [23]. The extracts were dried, dissolved and
analysed for triacylglycerides using the l-a-glycerol
phosphate oxidase kit [24] for the determination of
triglycerides (Roche Diagnostics). Samples were analysed
in triplicate and the results expressed as μg lipid per mg
liver weight. Rates of hepatic b-oxidation was assayed by
monitoring the palmitoyl-CoA-dependent reduction of
NAD to NADH in sub-fractionated liver homogenates,
as described previously [22], Samples were analysed in
triplicate and the results expressed as μmol NADH
produced per minute and mg protein.
Hepatic glycogen content
Liver homogenates (10%) were extracted in 80% ethanol
to remove glucose. An aliquot of each homogenate was
mixed with amyloglucosidase (Roche Applied Science)
and incubated at 60°C for 15 minutes to degrade glyco-
gen into glucose residuals. The samples were diluted and
incubated with 1 ml of Glucose Assay Reagent (o-Diani-
sidine Reagent + Glucose Oxidase/Peroxidase Reagent,
Sigma-Aldrich) at 37°C for 30 min, followed by the addi-
tion of 1 ml 12 N H2SO4 to stop the reaction. The absor-
bance of glucose was read at 540 nm. In parallel,
different concentrations of rabbit liver glycogen type III
(Sigma-Aldrich) were treated as the samples and used as
standard curve. Samples were analysed in duplicate and
the results determined as μg glycogen per μgp r o t e i n .
The Bradford protein assay was used to measure the con-
centration of protein (Bio-Rad Laboratories).
Hepatic glucose output
Rats were anesthetized with an intraperitoneal injection
of ketamine (Pfizer AB, Täby, Sweden) at a dose of
60-70 μg/g body weight. Livers were perfused in situ for
15 minutes without recirculation in a 37°C cabinet via
the portal vein using Krebs-Henseleit bicarbonate buffer,
pH 7.4, which was equilibrated with 95% O2 and 5%
CO2 as described previously [25]. No gluconeogenic pre-
cursors were present in the buffer. The perfusion pres-
sure was kept constant with a flow rate of 3.0-4.0 ml/
Table 1 Primers used for analysis of gene expression by real time quantitative RT-PCR
Accession no. Gene Gene name Forward primer (5’-3’) Reverse primer (5’-3’)
NM_017340 ACOX1 acyl-coenzyme A oxidase 1 AGCTGTGCTGAGGAACCTGT CTGGTGGATGCCTTTGACTT
NM_031559 CPT-1a carnitine palmitoyltransferase 1a AAGGTGCTGCTCTCCTACCA TACCTGGAATCTGTGAGGCC
NM_139192 SCD1 stearoyl-coenzyme A desaturase 1 GATATCCACGACCCCAGCTC TACCTTATCAGTGCCCTGGG
NM_017332 FAS fatty acid synthase CTTTGTGGCCTTCTCCTCTG GCAGTTTTGTGCTGGTTGAG
NM_199115 Angptl4 angiopoietin-like 4 CAGGCTACCACCCTGTTGAT TGGACAGAGAAGAAGCCCAT
NM_001024743 UGP2 UDP-glucose pyrophosphorylase 2 GGTTTGCTCGACACCTTCAT TACGAAGGCAAACTGAGGCT
NM_013098 G6Pase glucose-6-phosphatase CTACCTTGCGGCTCACTTTC GACCTCCTGTGGACTTTGGA
NM_198780 PEPCK phosphoenolpyruvate carboxykinase CCCAGGAGTCACCATCACTT GTGTCCCCCTTGTCTACGAA
NM_012571 GOT1 glutamate oxaloacetate transaminase 1 TCCAAGAACTTCGGGCTCTA GGAGTGGAAAGGAAACGTGA
NM_022402 Arbp acidic ribosomal phosphoprotein Pθ CAGCAGGTGTTTGACAATGG AAAGGGTCCTGGCTTTGCTC
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were collected at 2 minute intervals, starting five min
after perfusion initiation, and their glucose levels were
measured bya Glucometer (YSI 2300 STST PLUS,
VWR). Hepatic glucose output was calculated using the
mean glucose concentration in relation to flow rate and
hepatic dry weight. The wet and dry liver weights are
presented together with body weights in table 2. These
livers were not used for any other measurements. When
liver-derived perfusates were analysed using NMR spec-
troscopy (as described below), only one out of the six
collected fractions was used per liver.
Akt and AMPK phosphorylation
Whole liver cell lysates were obtained by homogeniz-
i n g1go fl i v e ri n3m lR I P Ab u f f e r( 5 0m MT r i s - H C l ,
pH 7.4, 1% Triton X-100, 150 mM NaCl, 5 mM
EDTA, 1 mM PMSF, 1 mM Na3VO4,1 0m MN a F ,1
μg/ml of aprotinin, leupeptin, and pepstatin), using a
polytrone PT-2000 (Kinematica AG), followed by 20
minutes of centrifugation (12 000 g). The resulting
supernatants were collected and subjected to protein
analyses. The degree of insulin signalling was analysed
by measuring the degree of insulin-dependent phos-
phorylation of Akt. Akt activation was determined by
analysing the amount of phosphorylated Akt (p-Akt-
Ser473) in relation to total Akt, using commercially
available ELISA kits (Biosource). Samples were
analysed in triplicate and the results determined as
unit p-Akt per ng total Akt. The degree of AMPK
phosphorylation was determined by immunoblotting as
described before [22], using antibodies detecting
p-AMPK-Thr172 or AMPK (1:1000) from Cell signaling.
Densitometry analysis was performed using the software
Quantity One 4.6.5 Basic (Bio-Rad Laboratories) to com-
pare the amount of phosphorylated AMPK (p-AMPK-
Thr172) in relation to total AMPK.
NMR spectroscopy
Liver perfusate samples were generated as described
above, and 500 μl from the third fraction was mixed
with 50 μL standard solution of Hexa deutero-4,4-
Dimethyl-4-silapentane-1-ammonium trifluoroacetate
(DSA), purchased from Onyx Scientific Ltd (Sunder-
land, United Kingdom), and D2O in 5 mm SampleJet
NMR tubes (Bruker BioSpin, Rheinstetten, Germany)
to a final DSA concentration of 0.36 mM and kept at
6°C until analysis. The NMR spectroscopic measure-
ments were made on a Bruker 600 MHz instrument
(Bruker BioSpin, Rheinstetten, Germany) operating at
600.23 MHz, equipped with a 5 mm inverse probe and
a SampleJet sample changer.
1H-NMR spectra were
acquired using a Carr-Purcell-Meiboom-Gill (CPMG)
spin-echo sequence to attenuate broad signals arising
from macromolecular components [26]. 512 transients
were acquired into 64 K data points using a spectral
width of 12019 Hz with a spin echo loop time of 76.8
ms and relaxation delay of 2.0 s with a total repetition
time of 4.82 s. Suppression of the water resonance was
achieved by presaturation during the relaxation delay
and the spin-echo loop. The time domain data were
processed using a exponential window function with a
line broadening factor of 0.3 Hz and zero-filled to yield
a real spectrum of 64 K data points in the frequency
domain after Fourier transformation. The spectra were
manually phase corrected using Topspin 1.3 (Bruker Bios-
pin) and imported into Chenomx NMR Suite 5.1 (Che-
nomx Inc., Edmonton, Canada) for further analysis.
Spectra were baseline corrected and referenced to the
DSA peak [27,28]. Metabolite signals were identified and
quantified using the metabolite library in the software [29].
Statistical analysis
Two-way ANOVA was performed to determine whether
there were significant effects of sex, fasting or insulin
treatment on measured variables or whether there was a
significant interaction i) between sex and fasting or ii)
between sex and insulin. Subsequently, if the interaction
was found to be significant, one-way ANOVA was con-
ducted and multiple comparisons with Fisher’s Least
Significant Difference (LSD) test was employed to com-
pare i) 4h-fasted males and females and the 12 h fasting
effect, or ii) saline-treated males and females and the
insulin effect in males and females. For
1H-NMR meta-
bolite data with low quantification quality, normality
could not be assumed and Friedman’s non-parametric
test was utilized to determine effect of insulin treatment
or sex effect. Where indicated, groups were also com-
pared using Student’s t-test. P-values < 0.05 were con-
sidered significant.
Results
Sex-dependent hepatic gene expression
Whole-genome rat oligo microarrays were used to iden-
tify genes with a sex-different expression in rat liver.
Out of 27 649 genes printed on the arrays, approxi-
mately 3 500 were detected in liver. With a 5% false
Table 2 Animal data related to HGO measurements
Female Male Significant
sex-difference
Body weight (g) 205.3 ± 6.6 289.4 ± 11.1 P < 0,0001
Wet liver weight (g) 10.0 ± 0.4 14.3 ± 0.7 P < 0.001
Wet liver weight
(% of body weight)
4.9 ± 0.1 4.9 ± 0.1
Dry liver weight (g) 2.2 ± 0.2 3.1 ± 0.3 P < 0.05
Dry liver weight
(% of body weight)
0.9 ± 0.2 1.1 ± 0.1
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(11%) transcripts among these were higher in females,
and 399 (11%) transcripts were significantly higher in
males. The differentially expressed gene products were
grouped into functional categories to enable an overview
of sex-differences within metabolic pathways. Results
related to lipid and carbohydrate turnover are listed in
t a b l e3 ,a n dt h ew h o l ed a t as e ti sa v a i l a b l ef r o mt h e
NCBI Gene Expression Omnibus database (GEO; http://
www.ncbi.nlm.nih.gov/geo/) using the series entry
GSE20601.
Among the transcripts of relevance for hepatic lipid
and carbohydrate metabolism (listed in table 3), those
involved in FA turnover constituted the biggest group.
The results point towards a female-predominant capacity
for hepatic uptake of long-chain fatty acids, synthesis of
TG, and assembly of VLDL particles, in line with pre-
vious reports [30,31]. In addition, a male-predominant
capacity for mitochondrial and peroxisomal oxidation of
FA was revealed. Sex-differences within this group of
gene products have been described before, and the results
obtained in the present study both confirm and extend
previous findings [12]. A clear sex-difference was also
observed in the expression of genes encoding proteins of
importance for cholesterol and bile acid synthesis, with
higher expression in female liver. Furthermore, male rats
had higher levels of gene products for glucose uptake and
synthesis of glycogen.
As described above, 22% of the genes expressed in rat
liver were identified as being sex-dependent (11% being
male-predominant and 11% female-predominant), as
determined by whole-genome microarrays, but only a
fraction of these are listed in table 3 (showing only
genes related to lipid and carbohydrate turnover).
Among those not shown in the table, a-2u-globulin
[32], carbonic anhydrase 3 [33], cyp2c13 [34] and
cyp2c11 were male-predominant, whereas alpha-1-B gly-
coprotein [35], insulin-like growth factor binding protein
1 [36], prolactin receptor [37], HNF-6 [38], cyp2c12 [39]
and cyp2c7 [40] were expressed to a greater extent in
females. These transcripts have previously been shown
to be sex-different in rat liver, substantiating the results
obtained in the present study.
Many gene products from metabolic pathways are
regulated in response to starvation. To investigate
whether males and females respond differently to this
type of metabolic stress, a new set of rats were fasted
for either 4 h (absorptive state) or 12 h (post-absorptive
state) and compared regarding hepatic gene expression.
Ten gene products of relevance for lipid and carbohy-
drate metabolism were selected for this purpose and
measured by RT-PCR. Seven of those were identified
from Table 3, whereas glucose-6-phosphatase (G6Pase),
acyl-coenzyme A oxidase 1 (ACOX1) and fatty acid
synthase (FAS) were selected due to their roles in cata-
lysing important rate-limiting steps in hepatic glucose
output, FA oxidation and FA synthesis. Interestingly,
most gene products showed a greater sex-difference
when the animals were starved (figure 1). Two-way
ANOVA revealed a significant sex-fasting interaction on
ACOX1 (P < 0.005) and carnitine palmitoyltransferase
1a (CPT-1a, P < 0.05) mRNA levels. Further analysis
with Fisher’s LDS established that males had higher
ACOX1 (P < 0.01) and CPT-1a (P < 0.01) levels than
females in the 12h-fasted state. UDP-glucose pyropho-
sphorylase 2 (UGP2) glutamate oxaloacetate transami-
nase 1 (GOT1), G6Pase and stearoyl-coenzyme A
desaturase 1 (SCD1) were also confirmed as sex-differ-
ent gene products (P < 0.05).
Hepatic lipid content, fatty acid oxidation, glycogen
content and glucose output
Hepatic triglyceride (TG) content, FA oxidation rate,
and ketone bodies in blood were analysed in 4 and 12h-
fasted males and females. Two-way ANOVA revealed
that 12h-fasted animals had higher FA oxidation rates
(P < 0,001) and ketone levels (P < 0,0001), without any
sex-fasting interaction (figure 2). No differences in TG
content were observed. However, males had higher
levels of hepatic glycogen as compared to females
(P < 0,005). The hepatic glycogen stores were reduced
in both sexes upon 12 h fasting (P < 0,0001), but the
sex-difference was maintained (figure 3A).
HGO was determined by in situ perfusion of the liver
in the absence of gluconeogenic precursors [25]. Interest-
ingly, glucose levels were higher in perfusates collected
from male rats (P < 0,0001), but there were no significant
differences in HGO between 4 and 12 h fasting (figure
3B). Since the animals were age-matched, body weights
and liver weights were different between the sexes. How-
ever, the liver weights were the same in males and
f e m a l e sw h e ne x p r e s s e da s%o fb o d yw e i g h t( t a b l e2 ) ,
suggesting a true sex-difference in the hepatic capacity to
release glucose, independent of body weight. When
blood glucose levels were determined at different dura-
tions of fasting, a significant decrease was observed after
12 h but sex-differences could not be detected at any
time point (figure 4). The discrepancy between glucose
levels in blood and liver perfusates might be explained by
differences in glucose uptake by peripheral tissues.
The sex-different rate of hepatic glucose output
reported above was obtained by determining glucose
levels in liver perfusates by the glucose oxidase method
using a glucose analyzer. To explore the possibility that
other low molecular weight compounds might be leav-
ing the liver in a sex-dependent manner, the perfusates
were also analysed using
1H-NMR spectroscopy. A typi-
cal NMR spectrum acquired from rat liver perfusates is
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Accession no. Gene name Fold sex-difference
Female Male
Fatty acid turnover
NM_031561 CD36 molecule 4.89
NM_144748 acyl-CoA synthetase medium-chain family member 2 4.53
NM_144750 lysophospholipase, asparaginase homolog 2.47
NM_053607 acyl-CoA synthetase long-chain family member 5 2.35
NM_012732 lipase A, lysosomal acid, cholesterol esterase 2.32
NM_199115 angiopoietin-like protein 4 2.26
NM_001107793 acyl-CoA synthetase short-chain family member 2 2.18
NM_017274 glycerol-3-phosphate acyltransferase, mitochondrial 1.98
NM_001012345 diacylglycerol O-acyltransferase homolog 2 1.91
XM_227765 microsomal triglyceride transfer protein 1.89
NM_001004085 carnitine acetyltransferase 1.84
NM_080576 apolipoprotein A-V 1.71
XM_215367 1-acylglycerol-3-phosphate O-acyltransferase 3 1.70
XM_231089 1-acylglycerol-3-phosphate O-acyltransferase 2 1.70
NM_138882 phospholipase A1 member A 1.69
NM_012556 fatty acid binding protein 1, liver 1.67
NM_001006995 acetyl-Coenzyme A acetyltransferase 2 1.60
NM_031736 solute carrier family 27 (fatty acid transporter), member 2 1.59
NM_017306 dodecenoyl-coenzyme A delta isomerase 1.52
NM_134383 ELOVL family member 6 15.64
NM_032082 hydroxyacid oxidase 2, long chain 10.35
NM_139192 stearoyl-CoA desaturase 1 3.60
NM_031841 stearoyl-CoA desaturase 2 3.06
NM_053674 phytanoyl-CoA hydroxylase 2.25
NM_031987 carnitine O-octanoyltransferase 2.16
NM_031559 carnitine palmitoyltransferase 1a 2.10
NM_130433 acetyl-Coenzyme A acyltransferase 2 2.02
NM_001034925 carnitine palmitoyltransferase 1c 1.83
NM_013196 peroxisome proliferator activated receptor alpha 1.67
NM_016986 acetyl-coenzyme A dehydrogenase, medium chain 1.63
NM_017075 acetyl-coenzyme A acetyltransferase 1 1.59
NM_012930 carnitine palmitoyltransferase 2 1.52
Retinoic acid turnover
NM_017158 cytochrome P450, family 2, subfamily c, polypeptide 7 2.70
NM_199208 retinol dehydrogenase type II 11.16
NM_145084 retinol saturase 2.58
Cholesterol and bile acid turnover
NM_012941 cytochrome P450, subfamily 51 2.38
NM_012690 ATP-binding cassette, sub-family B (MDR/TAP), member 4 2.37
NM_199115 Angiopoietin-like 4 2.26
XM_221100 ATP-binding cassette, sub-family A (ABC1), member 8a 2.25
NM_053754 ATP-binding cassette, sub-family G (WHITE), member 5 2.22
NM_053642 sterol-C5-desaturase 2.13
NM_022389 7-dehydrocholesterol reductase 1.74
NM_012942 cytochrome P450, family 7, subfamily a, polypeptide 1 1.69
NM_001033694 sterol regulatory element binding factor 2 1.57
NM_031840 farensyl diphosphate synthase 1.56
NM_057133 nuclear receptor subfamily 0, group B, member 2 2.05
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from the perfusion buffer, glucose, lactate, glycerol, sev-
eral amino acids and ketone bodies were among the
identified compounds (listed in table 4). Quantitative
analysis verified that perfusates generated from male
livers contained more glucose, as compared to females
(P < 0.01). There were also significantly higher levels of
lactate detected in male samples (P < 0.01).
Insulin-mediated effects
To evaluate the physiological significance of the herein
described measurements of hepatic glucose production,
the animals were injected (i.p.) with insulin 40 min
before initiating liver perfusions. As shown in figure 6A,
the rate of glucose output was reduced upon insulin
treatment in both male and female livers when com-
pared to saline-injected animals (P < 0.0001). Further-
more, two-way ANOVA revealed a significant sex-
insulin interaction on glucose levels (P < 0.005), with a
greater response in males. Sex-different effects on HGO
were also observed using data obtained by
1H-NMR
spectroscopy (table 4). However, the extent of insulin-
mediated HGO suppression was similar between the
sexes when expressed as % of basal glucose levels (glu-
cose analyzer, males 75% and females 71%;
1H-NMR
spectroscopy, males 89% and females 82%). This indi-
cates that male and female rat livers were equally sensi-
tive to insulin and that the sex-difference in HGO was
maintained upon insulin treatment.
Apart from glucose, other liver-derived analytes (lac-
tate, alanine, glutamate, glutamine, histidine, propionate
and formate) were also shown to be reduced in perfu-
sates upon insulin treatment (table 4). Two-way
ANOVA revealed a significant sex-insulin treatment
interaction on lactate levels (P < 0.05). Further analysis
with Fisher’s LDS established that control males had
higher glucose (P < 0.01) and lactate (P < 0.01) than
control females and that both glucose and lactate (P <
0.001) decreases with insulin treatment in males.
To test whether male and female livers respond
equally well to insulin at the level of insulin receptor
signalling, the responses to insulin were compared
between male and female rats regarding Akt-phosphory-
lation (Ser473) and gene expression. No sex-difference
Table 3: Sex-dependent hepatic expression of gene products from metabolic pathways (Continued)
Carbohydrate turnover
NM_053551 pyruvate dehydrogenase kinase, isoenzyme 4 2.33
NM_199118 glucosidase, alpha; acid 1.85
NM_012565 glucokinase 2.49
NM_001008893 lactate dehydrogenase D 2.49
BC076398 isocitrate dehydrogenase 2 (NADP+), mitochondrial 1.94
NM_012600 malic enzyme 1, NADP(+)-dependent, cytosolic 1.84
NM_017025 lactate dehydrogenase A 1.82
NM_012621 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 1.81
BC084711 UDP-glucose pyrophosphorylase 2 1.81
NM_012879 solute carrier family 2 (facilitated glucose transporter), member 2 1.79
NM_032080 glycogen synthase kinase 3 beta 1.66
Amino acid turnover
NM_022521 ornithine aminotransferase 1.91
NM_017159 histidine ammonia lyase 1.69
NM_022619 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 1.52
NM_030850 betaine-homocysteine methyltransferase 1.94
NM_021750 cysteine sulfinic acid decarboxylase 1.83
NM_053818 solute carrier family 6 (neurotransmitter transporter, glycine), member 9 1.82
NM_017084 glycine N-methyltransferase 1.64
NM_053962 serine dehydratase 1.62
NM_012531 catechol-O-methyltransferase 1.61
XM_219785 glycine dehydrogenase (decarboxylating) 1.58
NM_017134 arginase 1 1.56
NM_198731 choline dehydrogenase 1.55
Total RNA was extracted from male and female rat livers and sex-dependent gene products were identified using rat whole-genome oligo arrays. The data were
obtained using SAM at a false discovery rate of 5% and are represented as mean fold changes. Functional analysis was made but only genes involved in lipid,
carbohydrate and amino acid metabolism are listed here. All data are available from the NCBI Gene Expression Omnibus database http://www.ncbi.nlm.nih.gov/
geo/ using the series entry GSE20601.
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Figure 1 Sex-dependent mRNA expression of selected genes from metabolic pathways. mRNA expression levels of selected genes for
hepatic amino acid, carbohydrate and lipid metabolism were quantified in male and female rat liver by real-time PCR and normalized to the
housekeeping gene Arbp (n = 4 rats/group). Data are represented as means ± SEM, and asterisks indicate significant differences compared to
corresponding male group as determined by Student’s t-test.
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Figure 2 Effects of fasting on hepatic lipid content, fatty acid oxidation and blood ketone bodies. (A) Hepatic triglyceride content was
measured in lipid extracts from livers of male and female rats (n = 4 rats/group). (B) Rate of fatty acid oxidation was determined in liver
homogenates from male and female rats (n = 4 rats/group). (C) Circulating levels of ketone bodies were measured in a drop of blood collected
from the tip of the tail (n = 3-5 rats/group). Data are represented as means ± SEM, and asterisks indicate significant differences compared to the
corresponding non-starved group as determined by Student’s t-test.
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Page 8 of 17could be observed in the degree of Akt-phosphorylation
40 min after insulin treatment, using an ELISA assay
(figure 6B). The ratio between phosphorylated and total
Akt was increased by the same extent in males (2185%)
and females (2427%). Among the gene products from
figure 1, angiopoietin-like 4 (Angptl4) showed the most
robust response to insulin with a significant reduction
in mRNA levels upon this short-term (40 min) insulin
treatment. A similar degree of suppression was observed
in both sexes (fig 6C, males 47% and females 56%). The
effect on blood glucose levels was the same in males
(reduced from 6.1+0.3 to 2.5+0.3) and females (reduced
from 5.8+0.4 to 2.3+0.4) 40 min after insulin treatment.
Furthermore, males and females recovered equally well
from insulin-induced hypoglycaemia (data not shown).
Although a different dose of insulin might have given
different results, this indicates that male and female rats
responded equally well to the dose used in this study (5
mU/g body weight).
Plasma levels of insulin, glucagon and corticosterone
Overall, glycogen levels are increased in response to
insulin and decreased by glucagon, whereas the opposite
is true for gluconeogenesis. In addition, glucocorticoids
influence tissue responses to insulin (inhibiting) and glu-
cagon (stimulating). To find an explanation for the
higher glycogen content in male rats, plasma levels of
insulin, glucagon and corticosterone were determined.
No significant sex- or fasting-related differences in glu-
cagon or insulin were observed (table 5), whereas only
females had increased levels of corticosterone in
response to 12 h fasting. Importantly, males had higher
ratios of insulin to glucagon at both time points. The
highest ratio was observed in the absorptive males, and
the lowest in the fasted females. This might explain the
sex-different levels of hepatic glycogen, and since glyco-
gen serves as a substrate for glucose production it might
also explain the male-predominant HGO. It should also
be noted that males and females had the same blood
glucose levels at these time points (table 5). This
together with higher ratios of insulin to glucagon in
males indicates that the males were less sensitive to
insulin.
Hepatic AMP kinase
AMP kinase (AMPK) is an important energy sensor and
regulator of cellular fuel metabolism that is under the
control of AMP/ATP ratios [41], glycogen content [42]
as well as signals depending on hepatocyte receptors for
leptin [43] and adiponectin [44]. Activation of this
kinase decreases de novo lipid synthesis, facilitates FA
oxidation and down-regulates genes for gluconeogenesis.
To determine whether sex-differences in insulin to glu-
cagon ratios, glycogen levels, HGO rates and transcripts
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Figure 3 Sex-dependent hepatic glycogen content and glucose output. (A) Hepatic glycogen content was quantified in males and females
by the amyloglucosidase method (n = 7-9 rats/group). (B) Hepatic glucose output was measured in males and females by in situ liver perfusion
(n = 4 rats/group). Levels of glucose production were correlated to corresponding liver dry-weights. Data are represented as means ± SEM, and
asterisks indicate significant differences compared to corresponding male (*) or non-starved group (#) as determined by Student’s t-test
Gustavsson et al. BMC Biochemistry 2010, 11:38
http://www.biomedcentral.com/1471-2091/11/38
Page 9 of 17for gluconeogenesis might be related to differences in
AMPK activity, we assessedA M P Kp h o s p h o r y l a t i o n
(Thr172) in male and female livers. As shown in figure
7, the degree of AMPK phosphorylation was higher in
female livers, indicating a higher activity level of this
kinase in females.
Discussion
In the present study, we examined whether healthy male
and female rats differ regarding hepatic lipid and carbohy-
drate metabolism. Starting at the level of gene expression
by comparing sex-dependent transcript profiles from liver,
it was evident that the capacity for different metabolic
pathways might differ between males and females. Many
genes for the production of TG, cholesterol and VLDL
particles were found to be female-predominant, whereas
genes for FA oxidation were more expressed in males. In
line with this, female rats have previously been shown to
have higher rates of hepatic FA uptake [21,30], esterifica-
tion [21], VLDL-TG formation and output [31] as
compared to males. In the present study no differences in
hepatic TG content was detected, suggesting that a puta-
tive female-predominant capacity regarding TG synthesis
was compensated for by a greater VLDL-TG output.
Among the transcripts showing the biggest difference
between males and females, CD36 (also known as fatty
acid translocase) has been implicated as an important
player in the context of hepatic FA uptake. CD36 is
increased during situations of increased hepatic lipid
content [12,45,46] but reduced during starvation [47],
indicating that it might be involved in anabolic actions.
Thus, the degree of sex-different CD36 expression
depends on the metabolic state of the animal [47]. Simi-
larly, male-predominant responses to 12 h fasting were
obtained for ACOX1 and CPT-1a in this study. Taken
together, these differences might be part of a sex-differ-
ent system to handle metabolic alterations, giving rise to
secondary sex-differences in hepatic lipid metabolism. It
can therefore be speculated that although we could not
detect any sex-differences in TG levels, FA oxidation
rates or circulating levels of ketone bodies in this study,
a different metabolic state with e.g. higher blood levels
of non-esterified fatty acids (NEFA) might have gener-
ated differences in lipid turnover.
The peroxisome proliferator-activated receptor a
(PPARa) is a lipid-activated transcription factor that
controls a variety of genes in several pathways of lipid
metabolism [48,49]. During situations of increased adi-
pose lipolysis and availability of NEFA in the blood
stream, the liver will take up more NEFA which will
lead to PPARa activation and increased expression of
gene products for FA oxidation [50] and ketogenesis
[51]. Male rats have been shown to have higher levels of
hepatic PPARa [52] and to be more responsive to per-
oxisome proliferators than female rats [16-19], including
higher rates of FA oxidation. Our finding that starvation
induced the PPARa-dependent genes ACOX and
CPT-1a in males to a greater extent than in females
might thus be explained by higher levels of PPARa in
male liver.
Figure 4 Blood glucose levels in response to fasting. Blood glucose levels were measured in a drop of blood collected from the tip of the
tail at the indicated time-points after food removal (n = 10 rats/group). Data are represented as means ± SEM.
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Page 10 of 17An interesting sex-difference related to PPARa and
fuel metabolism has been described in mice, where
females have much better chances of surviving in a
model of defect mitochondrial FA oxidation [53]. When
mitochondrial b-oxidation was pharmacologically
blocked in mice deficient in PPARa (PPARa
-/-), TG
accumulated in liver and the animals died from hypogly-
cemia. This happened in 100% of the males but only in
25% of the females. Thus, female mice seem to be less
dependent on mitochondrial lipid oxidation. The
mechanisms behind these sex differences are not
known, but the metabolic phenotype of male PPARa
-/-
mice was rescued by a 2-week pre-treatment with estro-
gen [53].
Apart from controlling cellular lipid utilization,
PPARa is also an important mediator of gluconeogen-
esis [54-57]. Gluconeogenesis is fuelled by energy gener-
ated through b-oxidation, and fasted PPARa
-/- mice
develop fatty liver and hypoglycemia [58]. Since PPARa-
induced FA oxidation is linked to gluconeogenesis, a
higher degree of PPARa activation in males might also
explain the male-predominant expression of hepatic
Figure 5 Typical 600 MHz
1HN M Rs p e c t r u m( δ 0.5-5.6) of a male rat liver perfusate sample. Resonances from the buffer, HEPES and
acetate, as well as the residual water signal were cropped to reveal the more interesting liver-derived signals. The middle expansion shows in
detail a small portion of the ppm-axis. Assigned signals in the expanded region are (a) 3-hydroxybutarate, (b) lactate, (c) choline, (d) histidine, (e)
serine, (f) HEPES (
13C-satelite), and (g) glucose.
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Page 11 of 17Table 4 Liver-derived metabolites identified and quantified by
1H-NMR spectroscopy
Male Female
Liver metabolite Saline Insulin Saline Insulin Significant ANOVA effects
3-Hydroxybutyrate 162 ± 29.0 85.3 ± 38.8 130 ± 10.7 111 ± 15.7
Acetoacetate 12.2 ± 3.7 7.3 ± 3.5 13.7 ± 2.4 12.3 ± 0.7
Alanine 7.0 ± 2.6 2.2 ± 0.5 6.5 ± 1.8 2.9 ± 0.4 Insulin P < 0.05
Choline 7.6 ± 5.2 23 ± 0.9 5.5 ± 1.7 4.6 ± 1.2
Formate 5.5 ± 1.0 3.9 ± 0.8 6.5 ± 0.7 4.7 ± 0.2
a Insulin P < 0.05
Glucose 459 ± 96.1
e, f 48.8 ± 15.8
e 146 ± 66.4
f 27.4 ± 14.9
a Interaction P < 0.05
Glutamate 25.3 ± 6.2
a 5.7 ± 1.3
a 17.7 ± 2.9 14.7 ± 3.7 Insulin P < 0.05
Glutamine 41.7 ± 26.5 low
d 19.1 ± 3.7 low Insulin
g P < 0.01
Glycerol 13.9 ± 7.0 4.9 ± 0.6 5.5 ± 0.5 5.0 ± 0.9
Glycine 12.8 ± 5.1 6.8 ± 3.3 10.5 ± 2.4 8.1 ± 1.7
Histidine low low 2.6 ± 1.1
b low Insulin
g P < 0.05
Isoleucine 3.1 ± 0.8 2.5 ± 1.4
a 2.3 ± 0.2 3.9 ± 0.7
Lactate 94.6 ± 20.2
e, f 19.5 ± 2.2
e 33.0 ± 10.1
f 27.1 ± 8.5 Interaction P < 0.05
Leucine 6.1 ± 1.3 4.3 ± 2.0
a 3.8 ± 0.2 7.6 ± 1.3
Phenylalanine 2.6 ± 0.5
a low 1.0 ± 0.3 2.7 ± 0.6
b
Propionate 6.7 ± 1.4 2.5 ± 0.8
a 7.8 ± 2.1 4.6 ± 1.3
a Insulin P < 0.05
Serine 11.6 ± 5.2 3.2 ± 1.1
b 8.7 ± 0.7 11.7 ± 3.2
Succinate 4.8 ± 2.6 0.8 ± 0.2 1.6 ± 0.5
a 0.8 ± 0.2
Tyrosine low Low 0.9 ± 0.3
c 1.6 ± 0.5
c
Uridine low low ND ND Sex
g P < 0.05
Valine 4.7 ± 1.1 3.3 ± 1.6 3.1 ± 0.4 5.3 ± 1.0
Liver perfusates, generated from 12h-fasted male and female rats treated with saline or insulin (s.c.), were anylsed using
1H-NMR spectroscopy. The data
represent measured concentrations (μM) of analytes and are presented as means ± SEM (n = 4) together with results of statistical analysis.
a 1 measurement below limit of reliable quantification, still used in calculations
b 2 measurements below limit of reliable quantification, still used in calculations
c Not detectable in one sample imputed by lowest detected/2
d Low indicates not calculated due to multiple low or ND samples
e Male Saline vs Male Insulin, Fisher’s LSD, P < 0.001
f Male Saline vs Female Saline, Fisher’s LSD, P < 0.01
g Evaluated with Friedman’st e s t
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Figure 6 Effects of insulin on hepatic glucose output, Akt-phosphory l a t i o na n dA n g p t l 4m R N Ae x p r e s s i o ni n1 2 h - f a s t e dm a l ea n d
female rats. (A) Hepatic glucose output was measured in liver perfusates 40 min after saline- or insulin-treatment (n = 4 rats/group). (B) The
ratio between phosphorylated (p-Akt-Ser473) and total Akt was determined using ELISA in whole liver cell lysates derived from fasted rats 40
min after saline- or insulin-treatment (n = 6-7 rats/group). (C) Hepatic Angptl4 mRNA levels were quantified by real-time PCR and normalized to
the housekeeping gene Arbp (n = 4 rats/group). Data are represented as means ± SEM, and asterisks indicate significant differences compared
to corresponding saline-treated group as determined by Student’s t-test.
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Page 12 of 17G6Pase and PEPCK mRNA in this study. A large extent
of the hepatic energy requirement is covered by amino
acid oxidation. Hepatic amino acid transferases and dea-
minases contribute to this through the generation of
pyruvate and other glucogenic substrates. A male-predo-
minant expression of GOT1 (glutamate oxaloacetate
transaminase 1, also known as aspartate aminotransfer-
ase) was observed, which mirrored the mRNA levels of
G6Pase and PEPCK. GOT1 catalyzes the transfer of an
amino group from an amino acid (glutamate) to a
2-keto-acid to generate a new amino acid and the resi-
dual 2-keto-acid of the donor amino acid (alpha-
keto-glutarate). Alpha-keto-glutarate is a TCA cycle
intermediate and glutamate is one of the most impor-
tant glucogenic amino acids. Although various mechan-
isms might underlie the sex-different hepatic glucose
output, higher levels of these three important glucogenic
enzymes in males are likely to be involved.
1H-NMR spectroscopy analysis on rat liver perfusates
has to our knowledge not been performed before. Using
DSA as internal standard (instead of the more common
TSP or DSS) enabled absolute concentrations of meta-
bolites to be determined (20). Using this approach, glu-
cose, lactate, glycerol, propionate, several amino acids
(glutamine, glutamate, glycine, serine, alanine, leucine,
valine, isoleucine, phenylalanine, histidine and tyrosine)
and ketone bodies (3-hydroxybuturate and acetoacetate)
were identified as being released from the liver.
1H-NMR spectroscopy can be used to measure all kinds
of small molecule metabolites simultaneously but is rela-
tively insensitive compared to mass spectrometry-based
techniques. Since NMR is close to being a universal
detector, the identified metabolites are likely to be the
most abundant liver-derived endogenous compounds, at
least in 12h-fasted rats. Quantitative analysis verified
that perfusates generated from male livers contained
more glucose than female perfusates. Liver-derived
lactate was also higher in males, and there was a trend
towards higher levels of glycerol and the glucogenic
amino acids glutamine and glutamate in males. This
indicates that the male liver is more active in producing
and exporting not only glucose but also metabolites
important for glucose production.
A sex-difference in hepatic glucose output has as far as
we know not been described before, but there are reports
on male-predominant hepatic glycogen content, G6Pase
[59] and PEPCK [60] activities. PEPCK activity has further
been shown to be reduced by castration or estrogen treat-
ment. Estrogens have also been shown to decrease the
expression of PEPCK in virgin female rats [61] as well as
Table 5 Circulating levels of insulin, glucagon,
corticosterone and glucose
Male Female Significant
sex-difference
4 h fasting
Insulin (ng/ml) 2.43 ± 0.45 1.56 ± 0.04
Glucagon (pg/ml) 99.8 ± 6.2 100.9 ± 8.5
Corticosterone (ng/ml) 495.9 ± 9.9 531.5 ± 22.6
Insulin-Glucagon ratio 24.3 ± 4.1 16.0 ± 2.0 P < 0.05
Glucose (mM) 6.7 ± 0.3 6.4 ± 0.2
12 h fasting
Insulin (ng/ml) 3.99 ± 1.75 0.82 ± 0.16
Glucagon (pg/ml) 275.5 ± 122.4 100.9 ± 2.2
Corticosterone (ng/ml) 506.1 ± 20.2 587.4 ± 6.9 P < 0.005
Insulin-Glucagon ratio 16.5 ± 2.3 8.0 ± 1.4 P < 0.05
Glucose (mM) 4.8 ± 0.2 5.2 ± 0.2
Male and female rats were fasted for 4 or 12 h, blood samples were collected
and analyzed for insulin, glucagon, corticosterone and glucose. The ratio
between insulin and glucagon was calculated. The data are presented as
means ± SEM (n = 4) and analyzed using two-way ANOVA and Fisher’s LSD
test.
Figure 7 Sex-dependent degree of hepatic AMP kinase-
phosphorylation. The ratio between phosphorylated (p-AMPK-
Thr172) and total AMPK was determined in whole-cell lysates by
immunoblotting (upper section) and quantified by densitometry
analysis (lower section). Data are represented as means ± SEM, and
the asterisk indicates significant difference compared to
corresponding male group as determined by Student’s t-test.
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Page 13 of 17G6Pase protein levels and enzyme activity in ob/ob mice
[62]. Estrogens have therefore been proposed as an effec-
tive antihyperglycemic agent in this model of type 2
diabetes (T2D). Accordingly, estrogen receptor a deficient
(ERKO) mice develop fatty liver, have higher fasting blood
glucose, plasma insulin levels and impaired glucose toler-
ance [11]. Since estrogen levels are higher in fertile females
than males, estrogen signaling seems to be essential for
these hepatic sex-differences. However, other sex-depen-
dent hormones such as growth hormone (GH) are likely
to be of similar importance.
The secretion of GH is sexually dimorphic in rats [63]
and other species, including humans [64]. In adult male
rats, GH is secreted in episodic bursts at 3 to 4 h inter-
vals with low or undetectable levels between peaks,
whereas females have a more continuous pattern of
secretion. In rodents, biological effects of this sexually
differentiated pattern of GH secretion includes sex-
differences in body weight gain and longitudinal bone
growth [65], but also hepatic steroid metabolism [66].
Using hepatic gene expression profiling, we [12] and
others [13] have previously tried to estimate the degree
of sex-dependent genes that are controlled by GH. In
rats, at least 30% of hepatic sex-differences are explained
by the female-specific secretion of GH, through the
induction of female-predominat transcripts and suppres-
sion of male-predominant. Continuous administration of
GH has been shown to increase hepatic expression of
SREBP-1c and its downstream target genes [67,68], as
well as hepatic triglyceride synthesis and very low-
density lipoprotein (VLDL) secretion [69-71]. Further-
more, PPARa which is male-predominant in rat liver
has been shown to be suppressed by continuous GH
infusion in hypophysectomized [52,72] or old [68] rats
and by GH treatment in cultured rat hepatocytes [73].
Taken together, these findings suggest a connection
between sex-dependent, GH- and fatty acid-mediated
events of relevance for hepatic lipid metabolism.
There is an established link between gluconeogenesis
and glycogen synthesis, meaning that a higher rate of
glucose production from e.g. amino acids, lactate or
glycerol will also lead to a greater capacity to synthesise
glycogen. A similar pattern of mRNA expression was
observed for UGP2 as for the glucogenic enzymes
GOT1, G6Pase and PEPCK, suggesting a common
mechanism of regulation. Further experiments are
required to determine whether this explains the male-
predominant content of glycogen. Another interesting
sex-difference was observed regarding plasma levels of
insulin and glucagon. Male rats had higher ratios of
plasma insulin to glucagon levels, which might also con-
tribute to higher glycogen content in males. In spite of
this sex-difference in insulin to glucagon ratios, blood
glucose concentrations were the same in male and
female rats, which might be interpreted as male rats
being less sensitive to insulin. It should also be noted
that AMPK was Thr172-phosphorylated to lower
degrees in male livers, indicative of higher activity
through glucogenic pathways as compared to females.
Recent studies have revealed that glycogen can block
the activity of AMPK as well as the upstream AMPK
kinases LKB1 and CaMKKb [42]. Whether a cause-effect
relationship between higher insulin to glucagon ratios,
greater capacity for glycogen synthesis and less AMPK
activity exists in male rat livers, and whether this
explains the greater HGO in male rat livers observed in
this study, have to await further investigations.
The suppressive effect of insulin on hepatic Angptl4
(Angiopoietin-like 4, also known as fasting-induced adi-
pose factor) has to our knowledge not been described
before and deserves further studies. Angptl4 is a blood-
borne hormone directly involved in regulating glucose
homeostasis, lipid metabolism, and insulin sensitivity
[74]. Hepatic expression of Angptl4 is increased during
starvation [75] and reduced upon short-term high-fat
feeding [22]. Data has been presented suggesting that via
physical association with plasma lipoproteins [76],
Angptl4 acts as a powerful signal to prevent fat storage
and stimulate fat mobilization [77]. Thus, insulin might
mediate some of its anabolic effects through inhibition of
hepatic Angptl4. Angptl4 was one of the female-predomi-
nant gene products identified herein, and there was a
trend towards higher mRNA levels of Angpl4 in absorp-
tive females. This putative sex-difference disappeared
upon starvation due to increased levels in both sexes.
Although we believe that our findings reflect true
sex-differences within the liver, we realize that study
limitations exist. The significance of the sex differences
described here may thus be confounded by differences
in e.g. body composition, dietary intake, sensitivity to
nutrients, composition and differentiation of the liver, as
well as in dynamics of metabolism. However, efforts
were made to reduce such confounding factors by
recording essential parameters related body and tissue
weights and expression analysis of house-keeping genes.
Since sex-differences in the liver are related to actions
of sex-steroids one may predict that a complete analysis
of the metabolome would detect differences in sex-ster-
oids/metabolites. In the present study we did not detect
changes in steroids because we used techniques that
were not sensitive enough to detect this part of the
metabolome.
Conclusions
It is evident that fuel metabolism differs between male
and female animals, but also between men and women
[15,78,79]. In the post-absorptive state, plasma concen-
trations of NEFA are lower whereas glucose and insulin
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Page 14 of 17levels are higher in men than in women [80]. Further-
more, men have been shown to utilize less fat and more
carbohydrates and amino acids during endurance exer-
cise [81,82]. Data presented in this report are in line
with this and lend further support to the picture of
males having a greater carbohydrate and amino acid
turnover. Our results include higher ratios of insulin to
glucagon levels, higher levels of hepatic glycogen, lower
degree of hepatic AMPK phosphorylation, higher
expression of hepatic gluconeogenic genes and higher
hepatic glucose output in healthy male rats. Glycogen
storage and release of glucose are major functions of the
liver, and the possibility that they might be regulated by
sex-dependent mechanisms is intriguing. Sex-differences
in hepatic fuel metabolism are probably linked to differ-
ences in body composition and physiological demands.
Whether these differences are of importance during the
development of fatty liver, hepatic insulin resistance and
impaired glucose tolerance is not known, but it might
be speculated that they contribute to a higher risk of
developing T2 D in men during situations of insufficient
insulin production.
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